WHO ICTRP trial
Investigation the effect of aqueous extract of salvia mirzayanii in treatment of…
IRCT2015122725712N1 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT2015122725712N1 |
|---|---|
| Public title | Investigation the effect of aqueous extract of salvia mirzayanii in treatment of diabetes |
| Scientific title | Clinical trial of the effect of aqueous extract of Salvia mirzayani in control of blood sugar of type 2 diabetic patients in comparison with control group |
| Primary sponsor | Hormozgan University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 2 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Type 2 diabetes disease based on WHO guide line. Non insulin dependent diabetes;Non insulin dependent diabetes |
| Interventions | Intervention 1: Interventional group: Every day one hour after lunch, patients of interventional group receive 1 capsule containing 450 mg of aqueous extract of Salvia mirzayanii for 3 months. Intervention 2: Control group: Every day one… |
| Registration date | Apr 27, 2017 |
| Target size | 58 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: